Aptose Biosciences (APS) News Today → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free APS Stock Alerts C$1.34 -0.19 (-12.42%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17, 2024 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Thursday (APS)May 17, 2024 | markets.businessinsider.comBuy Rating for Aptose Biosciences on Tuspetinib’s Promising AML Study and Synergistic PotentialMay 15, 2024 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Reports Results for the First Quarter 2024May 14, 2024 | msn.comAPTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024May 14, 2024 | sfgate.comAptose Biosciences: Q1 Earnings SnapshotMay 14, 2024 | finance.yahoo.comAptose Biosciences Q1 Net Loss Falls, on Lower ExpensesMarch 28, 2024 | seekingalpha.comAptose Biosciences Inc. (APTO) Q4 2023 Earnings Call TranscriptMarch 25, 2024 | benzinga.comAptose Biosciences's Earnings: A PreviewJanuary 31, 2024 | finance.yahoo.comAptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment OptionDecember 20, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Wednesday (APS)December 9, 2023 | finance.yahoo.comAptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual MeetingNovember 30, 2023 | finance.yahoo.comAptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive RoleNovember 10, 2023 | finance.yahoo.comAptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comAptose Reports Results for the Third Quarter 2023November 2, 2023 | theglobeandmail.comAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual MeetingNovember 2, 2023 | finance.yahoo.comAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual MeetingOctober 30, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug TuspetinibOctober 26, 2023 | finance.yahoo.comAptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023October 20, 2023 | markets.businessinsider.comPromising Prospects of Tuspetinib Drive Buy Rating for Aptose Biosciences: An Analyst’s PerspectiveOctober 7, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc up on Friday (APS)August 25, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc up on Thursday (APS)August 22, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Monday (APS)August 11, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Reports Results for the Second Quarter 2023August 11, 2023 | finance.yahoo.comAptose Reports Results for the Second Quarter 2023August 7, 2023 | theglobeandmail.comAptose Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (APS)July 21, 2023 | theglobeandmail.comAptose Biosciences: Stocks Undervalued by Analyst Consensus on TSX (APS)June 27, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Biosciences Meets Nasdaq Minimum Bid Price ComplianceJune 5, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Biosciences Provides Update on Reverse Stock SplitMay 31, 2023 | finance.yahoo.comAptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023May 26, 2023 | seekingalpha.comAptose to sell up to $25M stock in the U.S.May 17, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc flat on Tuesday (APS)May 11, 2023 | finance.yahoo.comAptose Biosciences Inc.'s (TSE:APS) Path To ProfitabilityMay 10, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc down on Wednesday (APS)May 8, 2023 | finance.yahoo.comAptose Reports Results for the First Quarter 2023May 4, 2023 | finance.yahoo.comAptose to Participate in RBC Capital Markets 2023 Global Healthcare ConferenceMay 2, 2023 | theglobeandmail.comClosing Bell: Aptose Biosciences Inc up on Monday (APS)March 28, 2023 | finance.yahoo.comAptose Biosciences to Participate in Cantor’s The Future of Oncology Virtual SymposiumMarch 27, 2023 | finance.yahoo.comAptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Call TranscriptMarch 25, 2023 | finanznachrichten.deAptose Biosciences, Inc.: Aptose Reports Results for the Fourth Quarter and Full Year 2022March 10, 2023 | finance.yahoo.comAptose Reports Immaterial Financial Exposure to Silicon Valley BankMarch 2, 2023 | finance.yahoo.comAptose Biosciences to Present at Oppenheimer 33rd Annual Healthcare ConferenceDecember 30, 2022 | finance.yahoo.comWe Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth CarefullyDecember 12, 2022 | ca.finance.yahoo.comStocks in play: Aptose Biosciences IncSeptember 27, 2022 | finance.yahoo.comSeagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223September 13, 2022 | finance.yahoo.comAptose Strengthens Board of Directors with Appointment of Bernd R. Seizinger, M.D., Ph.D.September 12, 2022 | benzinga.comAptose's New "G3" Formulation of Luxeptinib Boosts BioavailabilityJuly 23, 2022 | finance.yahoo.comIs Aptose Biosciences (TSE:APS) In A Good Position To Invest In Growth?July 19, 2022 | finance.yahoo.comAptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022May 14, 2022 | marketbeat.comAptose Biosciences Inc. to Post Q2 2022 Earnings of ($0.17) Per Share, Oppenheimer Forecasts (TSE:APS)Aptose Biosciences Inc. (TSE:APS - Get Rating) (NASDAQ:APTO) - Stock analysts at Oppenheimer upped their Q2 2022 earnings per share (EPS) estimates for Aptose Biosciences in a report released on Monday, May 9th. Oppenheimer analyst M. Biegler now expects that the biotechnology company will post eMay 9, 2022 | finance.yahoo.comAptose Reports Results for the First Quarter 2022 Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Email Address On June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. APS Media Mentions By Week APS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APS News Sentiment▼0.000.78▲Average Medical News Sentiment APS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APS Articles This Week▼00▲APS Articles Average Week Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SVA News Today TH News Today PMN News Today DMT News Today MBX News Today IBT News Today COV News Today CZO News Today KNE News Today ATE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:APS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
